Following National Advertising Division Challenge, NutriDrip Voluntarily Modified or Discontinued Certain NutrIMMUNITY IV Drip Therapy Claims

New York, NY – May 30, 2024 – Following a challenge brought by BBB National Programs’ National Advertising Division as part of its routine monitoring program, NutriDrip/JMB Medical Group, PLLC discontinued certain advertising claims used to promote its NutrIMMUNITY IV Drip Therapy.

NutriDrip offers intravenous nutritional therapy treatment via fluids, electrolytes, vitamins, and minerals to deliver nutrients to the body.

The National Advertising Division (NAD) challenged a number of health-related claims, including claims that the Drip Therapy boosts immune defenses. NAD also challenged a testimonial relating to the efficacy of the drip therapy. 

NutriDrip objected to NAD’s jurisdiction on the grounds that its advertising is not “national advertising” as it is only directed to consumers in New York City and Las Vegas where its clinics are located. However, NAD determined that it has jurisdiction over the challenged claims because NutriDrip’s website is accessible from anywhere and NutriDrip’s advertising targets travelers, a national audience, for NutriDrip locations in or near hotels in both cities. 

NutriDrip informed NAD that it is permanently discontinuing or modifying the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the claims, for compliance purposes, as though NAD recommended their discontinuance or modification. 

In its advertiser statement, NutriDrip stated that it “agrees to comply and thanks NAD for its consideration.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB procedures, this release shall not be used for advertising or promotional purposes.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends T-Mobile Discontinue or Modify “Price Lock” Claim for 5G Home Internet Service

New York, NY – June 17, 2024 – The National Advertising Division recommended that T-Mobile US discontinue its “Price Lock” claim for 5G home internet service or modify the claim to explain how T-Mobile’s “Price Lock” policy differs from a “price lock” which locks the price for the term of a service.

Read the Decision Summary
Decision

National Advertising Division Recommends Agendia Modify or Discontinue Certain Claims for MammaPrint and BluePrint Breast Cancer Tests

New York, NY – June 13, 2024 – The National Advertising Division recommended that Agendia modify or discontinue certain claims regarding the superiority of its MammaPrint and BluePrint tests for black women, including claims that GHI’s Oncotype DX test is inappropriate for black women and that it is biased,...

Read the Decision Summary
Decision

Following National Advertising Division Challenge, Perfect Play Voluntarily Discontinues Earnings Claim for Solitaire Smash Mobile App Game

New York, NY – June 12, 2024 – Following a challenge brought by the National Advertising Division as part of its routine monitoring program, Perfect Play voluntarily discontinued the claim that consumers can win significant amounts of money by playing its Solitaire Smash mobile app game.  

Read the Decision Summary
Decision

National Advertising Division Recommends Telecom Business Solutions Modify its AI-Pro Advertising to Avoid Confusion with ChatGPT and OpenAI

New York, NY – June 11, 2024 – BBB National Programs’ National Advertising Division recommended that Telecom Business Solutions d/b/a AI-Pro.org, modify its AI-Pro advertising, which uses the terms “ChatGPT” and “GPT4,” to avoid confusion about the nature of AI-Pro’s products and services and its...

Read the Decision Summary